Work

Comparative efficacy of tisagenlecleucel (tisa-cel) and lisocabtagene maraleucel (liso-cel) in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.7535

Authors: Stephen J. Schuster, Jie Zhang, Hongbo Yang, Abhijit Agarwal, Wenxi Tang, Marcela Martinez-Prieto, Vamsi Bollu, Qiufei Ma, David Kuzan, Richard T. Maziarz, Marie José Kersten

Institutions: Abramson Cancer Center, University of Pennsylvania, Analysis Group (United States), Oregon Health & Science University, OHSU Knight Cancer Institute, Amsterdam UMC Location University of Amsterdam, University of Amsterdam

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3166249517

Cites:

Cited by: 3

Related to: 10